Press Release | NeoGenomics Laboratories

February 19, 2019

NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter

January 28, 2019

NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019

December 13, 2018

NeoGenomics Appoints Dr. Lawrence M. Weiss as Chief Scientific Officer

December 12, 2018

NeoGenomics Announces Pricing on Secondary Offering of Common Stock by Selling Stockholder

December 11, 2018

NeoGenomics Announces Secondary Offering of Common Stock by Selling Stockholder

December 10, 2018

NeoGenomics Completes Acquisition of Genoptix, Inc.

November 30, 2018

NeoGenomics Reports 17% Revenue Growth to Record $69 Million

October 30, 2018

QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients